Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Denardo

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
The Lancet. Oncology|April 9, 2016
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trialTimothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Cancer Discovery|March 8, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to ImmunotherapyDouglas V Faget, Xianmin Luo, Matthew J Inkman, et al.
Science Immunology|August 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancerGraham D Hogg, Alyssa G Weinstein, Natalie L Kingston, et al.
The Journal of Clinical Investigation|September 14, 2021
Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironmentXinming Su, Yalin Xu, Gregory C Fox, et al.
Cancer Research|May 25, 2016
Antagonizing Integrin β3 Increases Immunosuppression in CancerXinming Su, Alison K Esser, Sarah R Amend, et al.
Nature Communications|March 21, 2024
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancerAshenafi Bulle, Peng Liu, Kuljeet Seehra, et al.
Science Immunology|June 26, 2026
T<sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancerZoe C Schmiechen, Eduardo Cruz-Hinojoza, Audrey L Hilk, et al.
Nature Reviews. Cancer|January 26, 2020
A framework for advancing our understanding of cancer-associated fibroblastsErik Sahai, Igor Astsaturov, Edna Cukierman, et al.
NPJ Precision Oncology|October 19, 2023
High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survivalErik P Storrs, Prathamesh Chati, Abul Usmani, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Lancet. Oncology|April 9, 2016
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trialTimothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Cancer Discovery|March 8, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to ImmunotherapyDouglas V Faget, Xianmin Luo, Matthew J Inkman, et al.
Science Immunology|August 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancerGraham D Hogg, Alyssa G Weinstein, Natalie L Kingston, et al.
The Journal of Clinical Investigation|September 14, 2021
Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironmentXinming Su, Yalin Xu, Gregory C Fox, et al.
Cancer Research|May 25, 2016
Antagonizing Integrin β3 Increases Immunosuppression in CancerXinming Su, Alison K Esser, Sarah R Amend, et al.
Nature Communications|March 21, 2024
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancerAshenafi Bulle, Peng Liu, Kuljeet Seehra, et al.
Science Immunology|June 26, 2026
T<sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancerZoe C Schmiechen, Eduardo Cruz-Hinojoza, Audrey L Hilk, et al.
Nature Reviews. Cancer|January 26, 2020
A framework for advancing our understanding of cancer-associated fibroblastsErik Sahai, Igor Astsaturov, Edna Cukierman, et al.
NPJ Precision Oncology|October 19, 2023
High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survivalErik P Storrs, Prathamesh Chati, Abul Usmani, et al.
Pageof 10